Corresponding Author: George A. Diaz, MD, Providence Regional Medical Center Everett, 1700 13th St, Ste B3-018, Everett, WA 98201 (firstname.lastname@example.org).
Accepted for Publication: July 26, 2021.
Published Online: August 4, 2021. doi:10.1001/jama.2021.13443
Author Contributions: Dr Robicsek had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Diaz, Robicsek.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Diaz, Parsons, Meier, Hutchinson, Robicsek.
Critical revision of the manuscript for important intellectual content: Diaz, Gering, Hutchinson, Robicsek.
Statistical analysis: Diaz, Meier, Robicsek.
Administrative, technical, or material support: Parsons, Gering, Robicsek.
Conflict of Interest Disclosures: Dr Diaz reported receipt of clinical trial research support from Gilead Sciences, Regeneron, Roche, Boehringer Ingelheim, and Edesa Biotech and scientific advisory board membership for Safeology. No other disclosures were reported.
Additional Contributions: We acknowledge the patients included in this study and the caregiver teams across the Providence organization.
J , Peña Ortega
P , Bonilla Fernández
et al. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Rev Esp Cardiol (Engl Ed)
. Published online April 27, 2021. doi:10.1016/j.recesp.2021.03.009PubMedGoogle Scholar